| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/16/2010 | US7662599 Polyketide synthetase activity; vectors; host cells |
| 02/16/2010 | US7662591 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/16/2010 | US7662590 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 02/16/2010 | US7662589 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 02/16/2010 | US7662588 Producing vaccines; cloning and identification of novel outer membrane proteins (OMP); isolating recombinant polypeptides |
| 02/16/2010 | US7662587 Recombinant Escherichia host cell, comprising chimeric genetic construct, knockout mutation in gene gcvA (encoding the glycine cleavage enzyme), and knockout mutation in gene spr (encoding suppressor of prc); fusion proteins |
| 02/16/2010 | US7662586 host cells; tumor antigens; for treatment, prevention of cancer |
| 02/16/2010 | US7662583 Nutrient medium free of exogenous supply of UDP-glucose; quercetin glycosylation |
| 02/16/2010 | US7662557 Methods for producing members of specific binding pairs |
| 02/16/2010 | US7662556 Isolating and cloning full-lengh gene sequences using capped messenger RNA |
| 02/16/2010 | US7662548 Method of screening for modulators of HIV infection |
| 02/16/2010 | US7662415 Microbially expresses xylanases and their use as feed additives and other uses |
| 02/16/2010 | US7662399 BASB054 polypeptides |
| 02/16/2010 | US7662395 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 02/16/2010 | US7662391 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines |
| 02/16/2010 | US7662383 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction; polymerase chain reaction |
| 02/16/2010 | US7662381 isolated human monoclonal antibodies or antigen binding portion, that bind to IFNAR-1, capable of blocking the action of type I interferons; use in the treatment of immune mediated disorders, including autoimmune disorders, transplant rejection and Graft Versus Host Disease (GVHD) |
| 02/16/2010 | US7662380 ZAQ ligand-1 antibodies and uses thereof |
| 02/16/2010 | US7662377 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 02/16/2010 | US7662375 Use of glucose-6-phosphate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 02/16/2010 | US7662374 Dual-specificity antibody having specificity for both an activated erbB2 receptor and erbB1 dimers, without significant affinity for monomeric EGFr that is not activate; specificity of the antibodies is due to their recognition and binding of activation epitopes; diagnosis, imaging and for treating tumor |
| 02/16/2010 | CA2224444C Type f botulinum toxin and use thereof |
| 02/16/2010 | CA2223701C Fgf9 as a specific ligand for fgfr3 |
| 02/16/2010 | CA2177612C Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor |
| 02/11/2010 | WO2010016943A2 Nutrient monitoring and feedback control for increased bioproduct production |
| 02/11/2010 | WO2010016526A1 Pharmaceutical composition for treatment and prevention of cancer |
| 02/11/2010 | WO2010016069A1 A process for preparation of insulin compounds |
| 02/11/2010 | WO2010015722A1 Cells producing glycoproteins having altered glycosylation patterns and methods and use thereof |
| 02/11/2010 | WO2009054873A4 Anti-rantes antibodies and methods of use thereof |
| 02/11/2010 | US20100037348 Nucleotide sequences coding insecticidal protein for use in transformation and generation of plants resistant to lepidopteran or coleopteran pest; pesticides; biological pest control |
| 02/11/2010 | US20100036100 T cell proteins and nucleotides encoding the same |
| 02/11/2010 | US20100036097 Mutant Interleukin-2 (IL-2) Polypeptides |
| 02/11/2010 | US20100036096 Compositions and methods for producing recombinant proteins |
| 02/11/2010 | US20100036091 Antibody-based diagnostics and therapeutics |
| 02/11/2010 | US20100035818 Optimized expression of hpv 52 l1 in yeast |
| 02/11/2010 | US20100035813 Recombinant e-selectin made in insect cells |
| 02/11/2010 | US20100035804 Polypeptide antagonist |
| 02/11/2010 | US20100035362 Bio-silica chip comprising silica binding protein and method for fabricating the same |
| 02/11/2010 | US20100035301 Beta-mannanase from coffee berry borer, hypothenemus hampei, and uses thereof |
| 02/11/2010 | US20100035300 Producing a Target Protein Using Intramolecular Cleavage by TEV Protease |
| 02/11/2010 | US20100035299 Methods for the purification of polypeptide conjugates |
| 02/11/2010 | US20100035298 Hepatocyte Bioreactor System For Long Term Culture of Functional Hepatocyte Spheroids |
| 02/11/2010 | US20100035256 Enduracidin biosynthetic gene cluster from streptomyces fungicidicus |
| 02/11/2010 | US20100034854 Compositions of activated botulinum holotoxin type B (150 KD) |
| 02/11/2010 | US20100034826 Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and methods for using anti-ptk7 antibodies |
| 02/11/2010 | US20100034807 Methods and compositions for discovery of target-specific antibodies using antibody repertoire array (ara) |
| 02/11/2010 | US20100034738 Structural Variants of Antibodies for Improved Therapeutic Characteristics |
| 02/11/2010 | CA2733362A1 Cells producing glycoproteins having altered glycosylation patterns and methods and use thereof |
| 02/11/2010 | CA2733223A1 Pharmaceutical composition for treatment and prevention of cancers |
| 02/11/2010 | CA2733075A1 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi) |
| 02/10/2010 | EP2151493A1 Host cells containing multiple integrating vectors |
| 02/10/2010 | EP2151454A2 Platelet-derived growth factor D, DNA coding therefor, and uses thereof |
| 02/10/2010 | EP2151244A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/10/2010 | EP2150618A1 Il-12 immunotherapy for cancer |
| 02/10/2010 | EP2150561A1 Demannosylated recombinant factor vii for the treatment of patients with haemophilia a |
| 02/10/2010 | EP1532261B1 Methods and dna constructs for high yield production of polypeptides |
| 02/10/2010 | EP1530637B1 Subtilisin carlsberg proteins with reduced immunogenicity |
| 02/10/2010 | EP1354896B1 Monoclonal antibody directed against the human bst2 antigen |
| 02/10/2010 | CN101646780A Apparatus and methods for osmotically shocking cells |
| 02/10/2010 | CN101646779A Process for producing and purifying factor viii and its derivatives |
| 02/10/2010 | CN101643789A RNA interference mediating small RNA molecules |
| 02/10/2010 | CN101643767A Method for preparing almond peptide from almond dregs |
| 02/10/2010 | CN101643766A Method for preparing hydrolyzed collagen protein by fresh animal skin |
| 02/10/2010 | CN101643765A Positive growth factor for bifidus and method for preparing same |
| 02/10/2010 | CN101643764A Supplemented culture medium of proinsulin produced by fermentation and supplemented culture optimization method |
| 02/10/2010 | CN101643763A Method for preparing recombinant human programmed cell death 5 |
| 02/10/2010 | CN101643732A A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 02/10/2010 | CN100588661C Process for preparing recombined placental growth factor |
| 02/09/2010 | US7659385 Polynucleotides encoding molecules designated LDCAM |
| 02/09/2010 | US7659384 Polynucleotides encoding fully human antibodies against human 4-1BB |
| 02/09/2010 | US7659380 Method of isolation and purification of trypsin from pronase protease and use thereof |
| 02/09/2010 | US7659375 Interleukin specific immunoglobulin for prevention and treatment of vision, autoimmune, inflammatory and diabetic disorders |
| 02/09/2010 | US7659374 Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 02/09/2010 | US7659373 Producing such EPO products characterized by a high proportion of N-acetyl-lactosamine units or/and tetraantennary branches in the carbohydrate structure |
| 02/09/2010 | US7659371 Patched polypeptides and uses related thereto |
| 02/09/2010 | US7659241 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 02/09/2010 | US7659115 Nucleic acid encoding human transductin-1 polypeptide |
| 02/09/2010 | US7659112 Using transgenic worms as bioreactors for propagation of cytokine proteins |
| 02/09/2010 | US7659103 Nucleic acid construct containing fulllength genome of human hepatitis C virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus Particle |
| 02/09/2010 | US7659094 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/09/2010 | US7659092 Comprising a non-cytotoxic protease capable of cleaving a protein of the exocytic fusion apparatus of a nociceptive sensory afferent |
| 02/09/2010 | US7659065 Transgenic fungi expressing Bcl-2 and methods of using Bcl-2 or portions thereof for improving biomass production, survival, longevity and stress resistance of fungi |
| 02/09/2010 | US7658934 Chlamydia antigens and protein vaccine |
| 02/09/2010 | US7658931 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 02/09/2010 | US7658920 Method of inhibiting the activity of growth factor homolog ZVEGF3 |
| 02/09/2010 | US7658916 Methods of enhancing lysosomal storage disease therapy by modulation of cell surface receptor density |
| 02/09/2010 | CA2378431C Peptides that lower blood glucose levels |
| 02/09/2010 | CA2370694C Extraction of integral membrane proteins |
| 02/09/2010 | CA2350417C Dna-protein fusions and uses thereof |
| 02/09/2010 | CA2349875C Dna encoding a growth factor specific for epithelial cells |
| 02/09/2010 | CA2328416C Antibody and use thereof |
| 02/09/2010 | CA2295878C Increasing production of proteins in gram-positive microorganisms |
| 02/09/2010 | CA2205910C Plasmids suitable for il-2 expression |
| 02/09/2010 | CA2198968C Process for production of secretory kex2 derivatives |
| 02/09/2010 | CA2195799C Bacterial production of hydrophobic polypeptides |
| 02/04/2010 | WO2010013830A1 Nucleic acid occurring in blood from hepatitis patient, polypeptide encoded by the nucleic acid, and use of the same |
| 02/04/2010 | WO2010013789A1 Protein production method, fusion protein, and antiserum |
| 02/04/2010 | WO2010012805A1 Constructs and methods for the production and secretion of polypeptides |
| 02/04/2010 | WO2010012424A1 Chaperone “toolbox” |
| 02/04/2010 | WO2010012102A1 Family 6 cellulase with decreased inactivation by lignin |